Literature DB >> 10934198

Functional complementation of BLNK by SLP-76 and LAT linker proteins.

J Wong1, M Ishiai, T Kurosaki, A C Chan.   

Abstract

Recent studies have demonstrated a requirement for the SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa) and LAT (linker for activation of T cells) adaptor/linker proteins in T cell antigen receptor activation and T cell development as well as the BLNK (B cell linker) linker protein in B cell antigen receptor (BCR) signal transduction and B cell development. Whereas the SLP-76 and LAT adaptor proteins are expressed in T, natural killer, and myeloid cells and platelets, BLNK is preferentially expressed in B cells and monocytes. Although BLNK is structurally homologous to SLP-76, BLNK interacts with a variety of downstream signaling proteins that interact directly with both SLP-76 and LAT. Here, we demonstrate that neither SLP-76 nor LAT alone is sufficient to restore the signaling deficits observed in BLNK-deficient B cells. Conversely, the coexpression of SLP-76 and LAT together restored BCR-inducible calcium responses as well as activation of all three families of mitogen-activated protein kinases. Together, these data suggest functional complementation of SLP-76 and LAT in T cell antigen receptor function with BLNK in BCR function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934198     DOI: 10.1074/jbc.M004467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  BLNK mediates Syk-dependent Btk activation.

Authors:  Y Baba; S Hashimoto; M Matsushita; D Watanabe; T Kishimoto; T Kurosaki; S Tsukada
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 2.  Adapters in lymphocyte signaling.

Authors:  Albrecht Leo; Jürgen Wienands; Gottfried Baier; Vaclav Horejsi; Burkhart Schraven
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways.

Authors:  Sonja I Gringhuis; Ellen A M Papendrecht-van der Voort; Angela Leow; E W Nivine Levarht; Ferdinand C Breedveld; Cornelis L Verweij
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT.

Authors:  D Yablonski; T Kadlecek; A Weiss
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells.

Authors:  Tomoko Taguchi; Nobutaka Kiyokawa; Hisami Takenouch; Jun Matsui; Wei-Ran Tang; Hideki Nakajima; Kyoko Suzuki; Yusuke Shiozawa; Masahiro Saito; Yohko U Katagiri; Takao Takahashi; Hajime Karasuyama; Yoshinobu Matsuo; Hajime Okita; Junichiro Fujimoto
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 6.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21

7.  The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85.

Authors:  Thomas Oellerich; Vanessa Bremes; Konstantin Neumann; Hanibal Bohnenberger; Kai Dittmann; He-Hsuan Hsiao; Michael Engelke; Tim Schnyder; Facundo D Batista; Henning Urlaub; Jürgen Wienands
Journal:  EMBO J       Date:  2011-08-05       Impact factor: 11.598

8.  Cooperative PSGL-1 and CXCR2 signaling in neutrophils promotes deep vein thrombosis in mice.

Authors:  Tadayuki Yago; Zhenghui Liu; Jasimuddin Ahamed; Rodger P McEver
Journal:  Blood       Date:  2018-08-01       Impact factor: 25.476

9.  Glycerol monolaurate inhibition of human B cell activation.

Authors:  Micaela G Fosdick; Shannon Loftus; Isabella Phillips; Zeb R Zacharias; Jon C D Houtman
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.